Ligand Snaps Up Pfenex For Half A Billion
Value Of Transaction Could Top $500m Depending On Regulatory Milestone
Ligand Pharmaceuticals has struck a deal to acquire Pfenex in a transaction valued at up to $516m.

Ligand Pharmaceuticals has struck a deal to acquire Pfenex in a transaction valued at up to $516m.